Experiences of Australian men diagnosed with advanced prostate cancer: A qualitative study

BMJ Open

Volumn 8, Issue 2, 2018, Pages

  Chambers, Suzanne K ^a,b,c,d,e,f   Hyde, Melissa K ^a,b   Laurie, Kirstyn ^a,b   Legg, Melissa ^a,b   Frydenberg, Mark ^c,g,h   Davis, Ian D ^c,h   Lowe, Anthony ^a,c,d   Dunn, Jeff ^a,b,c,e  

^a GRIFFITH UNIVERSITY   (Australia)

^b CANCER COUNCIL QUEENSLAND   (Australia)

^c Australian and New Zealand Urogenital and Prostate Cancer Trials Group   (Australia)

^d PROSTATE CANCER FOUNDATION OF AUSTRALIA   (Australia)

^e UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^f EDITH COWAN UNIVERSITY   (Australia)

^g SOUTHERN HEALTH   (Australia)

^h MONASH UNIVERSITY   (Australia)

Author keywords

advanced cancer; life course; masculinities; metastatic; prostate cancer; supportive care needs

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AUSTRALIAN; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CASTRATION RESISTANT PROSTATE CANCER; CLINICAL ARTICLE; COOPERATION; CROSS-SECTIONAL STUDY; DIGITAL RECTAL EXAMINATION; DOMESTIC PARTNER; FAMILY; FEAR; HEALTH CARE; HEALTH CARE ACCESS; HUMAN; INTERPERSONAL COMMUNICATION; INTIMACY; LIFE EVENT; MALE; MASCULINITY; METASTASIS; MIDDLE AGED; OPEN ENDED QUESTIONNAIRE; PATIENT ATTITUDE; PEER GROUP; PERSONAL EXPERIENCE; PHYSICAL CAPACITY; PROSTATE CANCER; QUALITATIVE RESEARCH; QUALITY OF LIFE; SEXUALITY; SUPPORT GROUP; TELEPHONE INTERVIEW; VERY ELDERLY; AUSTRALIA; COPING BEHAVIOR; INTERVIEW; PROSTATE TUMOR; PSYCHOLOGY; QUESTIONNAIRE; SOCIAL SUPPORT;

ADAPTATION, PSYCHOLOGICAL; AGED; AGED, 80 AND OVER; AUSTRALIA; COMMUNICATION; CROSS-SECTIONAL STUDIES; HUMANS; INTERVIEWS AS TOPIC; MALE; MASCULINITY; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITATIVE RESEARCH; SOCIAL SUPPORT; SURVEYS AND QUESTIONNAIRES;

EID: 85052842107     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-019917     Document Type: Article

References (42)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer, 2013. globocan. iarc. fr/Default. aspx (accessed 8th Apr 2017)
2. Australian Institute of Health and Welfare. Cancer in Australia 2017. Cancer series no. 101. Cat. No. CAN 100. Canberra, Australia: AIHW, 2017.
3. National Cancer Institute. SEER Cancer stat facts: prostate cancer. Bethesda, MD: National Cancer Institute, 2016. http:// seer. cancer. gov/ statfacts/ html/ prost. html (accessed 8th Apr 2017).
4. Luo Q, Yu XQ, Smith DP, et al. A population-based study of progression to metastatic prostate cancer in Australia. Cancer Epidemiol 2015;39:617-22.
5. American Cancer Society. Cancer facts & figures 2017. Atlanta,GA: American Cancer Society, 2017.
6. Crawford ED, Petrylak D, Sartor O. Navigating the evolving therapeutic landscape in advanced prostate cancer. Urol Oncol 2017;35S:S1-13.
7. Heidenreich A, Bastian PJ, Bellmunt J, et al. Guidelines on prostate cancer 2012: European Association of Urology, 2012.
8. Afshar M, Evison F, James ND, et al. Shifting paradigms in the estimation of survival for castration-resistant prostate cancer: a tertiary academic center experience. Urol Oncol 2015;33:338.e1-7.
9. James ND, de Bono JS, Spears MR, et al. Abiraterone for prostate cancer not previously treated with hormone therapy. N Engl J Med 2017;377:338-51.
10. Fizazi K, Tran N, Fein L, et al. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. N Engl J Med 2017;377:352-60.
11. Gilbert DC, Duong T, Kynaston HG, et al. Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer. BJU Int 2017;119:667-75.
12. Resnick MJ, Penson DF. Quality of life with advanced metastatic prostate cancer. Urol Clin North Am 2012;39:505-15.
13. Bill-Axelson A, Garmo H, Lambe M, et al. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden. Eur Urol 2010;57:390-5.
14. Bloch S, Love A, Macvean M, et al. Psychological adjustment of men with prostate cancer: a review of the literature. Biopsychosoc Med 2007;1:2.
15. Chambers SK, Occhipinti S, Foley E, et al. Mindfulness-based cognitive therapy in advanced prostate cancer: a randomized controlled trial. J Clin Oncol 2017;35:291-7.
16. Eton DT, Lepore SJ. Prostate cancer and health-related quality of life: a review of the literature. Psychooncology 2002;11:307-26.
17. Clark JA, Wray NP, Ashton CM. Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol 2001;19:72-80.
18. Chambers SK, Hyde MK, Smith DP, et al. New challenges in psycho-oncology research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications. Psychooncology 2017;26:873-913.
19. Carter N, Bryant-Lukosius D, DiCenso A, et al. The supportive care needs of men with advanced prostate cancer. Oncol Nurs Forum 2011;38:189-98.
20. Paterson C, Kata SG, Nandwani G, et al. Unmet supportive care needs of men with locally advanced and metastatic prostate cancer on hormonal treatment. Cancer Nurs 2017;40:497-507.
21. Chambers SK, Hyde MK, Oliffe JL, Zajdlewicz L, et al. Measuring masculinity in the context of chronic disease. Psychol Men Masc 2015;17:228-42.
22. Chambers SK, Chung E, Wittert G, et al. Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment. Transl Androl Urol 2017;6:60-8.
23. Dunn J, Casey C, Sandoe D, et al. Advocacy, support and survivorship in prostate cancer. Eur J Cancer Care 2017;1:e12644.
24. Davidsen AS. Phenomenological approaches in psychology and health sciences. Qual Res Psychol 2013;10:318-39.
25. Lopez KA, Willis DG. Descriptive versus interpretive phenomenology: their contributions to nursing knowledge. Qual Health Res 2004;14:726-35.
26. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101.
27. Wojnar DM, Swanson KM. Phenomenology: an exploration. J Holist Nurs 2007;25:172-80.
28. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349-57.
29. Wood JV. Theory and research concerning social comparisons of personal attributes. Psychol Bull 1989;106:231-48.
30. Jenkins VA, Fallowfield LJ, Jenkins VA. No man's land: information needs and resources of men with metastatic castrate resistant prostate cancer. Support Care Cancer 2016;24:4471-3.
31. AIHW. Cancer in Australia 2010: an overview. Canberra: Australian Institute of Health and Welfare, 2010.
32. Gillessen S, Attard G, Beer TM, et al. Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
33. Lepor H. Opinion makers: revisiting the USPSTF Decision on PSA Tests-Urologist Herbert Lepor, MD, sets forth 'sensible solution': Medpage Today, 2016.
34. Evans J, Frank B, Oliffe JL, et al. Health, Illness, Men and Masculinities (HIMM): a theoretical framework for understanding men and their health. J Mens health 2011;8:7-15.
35. Forsythe LP, Kent EE, Weaver KE, et al. Receipt of psychosocial care among cancer survivors in the United States. J Clin Oncol 2013;31:1961-9.
36. Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J Adv Nurs 2005;49:616-23.
37. Roesch SC, Adams L, Hines A, et al. Coping with prostate cancer: a meta-analytic review. J Behav Med 2005;28:281-93.
38. King AJ, Evans M, Moore TH, et al. Prostate cancer and supportive care: a systematic review and qualitative synthesis of men's experiences and unmet needs. Eur J Cancer Care 2015;24:618-34.
39. Roberts D, Calman L, Large P, et al. A revised model for coping with advanced cancer. Mapping concepts from a longitudinal qualitative study of patients and carers coping with advanced cancer onto Folkman and Greer's theoretical model of appraisal and coping. Psychooncology 2018;27:229-35.
40. Rivas C, Matheson L, Nayoan J, et al. Ethnicity and the prostate cancer experience: a qualitative metasynthesis. Psychooncology 2016;25:1147-56.
41. Zopf EM, Newton RU, Taaffe DR, et al. Associations between aerobic exercise levels and physical and mental health outcomes in men with bone metastatic prostate cancer: a cross-sectional investigation. Eur J Cancer Care 2017;26:e12575.
42. Carter N, Miller PA, Murphy BR, et al. Healthcare providers' perspectives of the supportive care needs of men with advanced prostate cancer. Oncol Nurs Forum 2014;41:421-30.